Substituted pyridines and pyridazines with angiogenesis inhibiting activity
Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) wherein the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; R1 and R2 may be defined...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English Slovak |
Published |
07.09.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) wherein the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; R1 and R2 may be defined independent substituents or together may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermeability processes using these materials are also disclosed.
Substituované pyridíny a pyridazíny s aktivitou inhibície angiogenézy, ktoré majú všeobecný štruktúrny vzorec (I), kde kruh obsahujúci A, B, D, E a L je fenyl alebo heterocyklus obsahujúci dusík; skupiny X a Y môžu byť ľubovoľné z definovaného súboru spájajúcich členov; R1 a R2 môžu byť definované nezávisle substituenty alebo spolu môžu vytvárať mostík predstavujúci kruh; kruh J môže byť aryl, pyridyl alebo cykloalkylová skupina; a skupiny G môžu byť ľubovoľné z definovaného súboru substituentov. Riešenie sa tiež týka farmaceutických prostriedkov a použitia týchto zlúčenín na výrobu liečiva na liečenie cicavca, ktorý trpí stavom charakterizovaným abnormálnou angiogenézou alebo hyperpermeabilitou. |
---|---|
AbstractList | Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) wherein the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; R1 and R2 may be defined independent substituents or together may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermeability processes using these materials are also disclosed.
Substituované pyridíny a pyridazíny s aktivitou inhibície angiogenézy, ktoré majú všeobecný štruktúrny vzorec (I), kde kruh obsahujúci A, B, D, E a L je fenyl alebo heterocyklus obsahujúci dusík; skupiny X a Y môžu byť ľubovoľné z definovaného súboru spájajúcich členov; R1 a R2 môžu byť definované nezávisle substituenty alebo spolu môžu vytvárať mostík predstavujúci kruh; kruh J môže byť aryl, pyridyl alebo cykloalkylová skupina; a skupiny G môžu byť ľubovoľné z definovaného súboru substituentov. Riešenie sa tiež týka farmaceutických prostriedkov a použitia týchto zlúčenín na výrobu liečiva na liečenie cicavca, ktorý trpí stavom charakterizovaným abnormálnou angiogenézou alebo hyperpermeabilitou. |
Author | BOYER STEPHEN JAMES LEE WENDY NAGARATHNAM DHANAPALAN DIXON JULIE A SU NING JOE TEDDY KITE SIBLEY ROBERT N DUMAS JACQUES P KLUENDER HAROLD C. E |
Author_xml | – fullname: SU NING – fullname: KLUENDER HAROLD C. E – fullname: LEE WENDY – fullname: JOE TEDDY KITE – fullname: DUMAS JACQUES P – fullname: BOYER STEPHEN JAMES – fullname: NAGARATHNAM DHANAPALAN – fullname: SIBLEY ROBERT N – fullname: DIXON JULIE A |
BookMark | eNrjYmDJy89L5WTwDi5NKi7JLCktSU1RKKgsykzJzEstVkjMg_ISq8D88sySDKBgemZ-eiqQn1mskJmXkZmUWZKZl66QmFySWZZZUsnDwJqWmFOcyguluRkU3FxDnD10Uwvy41OLCxKTgXpL4oO9jSzMTQzNnZzMjIlQAgDBVjha |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | Substituované pyridíny a pyridazíny s inhibičným účinkom na angiogenézu a ich použitie |
ExternalDocumentID | SK287417BB6 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_SK287417BB63 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:56:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Slovak |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_SK287417BB63 |
Notes | Application Number: SK20020000591 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100907&DB=EPODOC&CC=SK&NR=287417B6 |
ParticipantIDs | epo_espacenet_SK287417BB6 |
PublicationCentury | 2000 |
PublicationDate | 20100907 |
PublicationDateYYYYMMDD | 2010-09-07 |
PublicationDate_xml | – month: 09 year: 2010 text: 20100907 day: 07 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | BAYER CORPORATION |
RelatedCompanies_xml | – name: BAYER CORPORATION |
Score | 2.78707 |
Snippet | Substituted pyridines and pyridazines having angiogenesis inhibiting activity and generalized structural formula (I) wherein the ring containing A, B, D, E,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100907&DB=EPODOC&locale=&CC=SK&NR=287417B6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4gGvWmqBFf2YPprbGypbWHxoS2hEgEImi4kW7Zwl5aQmuM_96ZpagXve0j2Uwmmdlv5_EtwK1EjJy4gpuulPhA4S3XFClvmZadJtwTLckTXSA7cHqv9tO0Pa3BctsLo3lCPzQ5IlpUgvZean-9-glihbq2srgTCpfyx-7ED43qdXyPiMFyjbDjR6NhOAyMIPDHfWPw4hOtO2InZwd2CUQTy3701qGelNXvC6V7BHsjPCsrj6EmswYcBNt_1xqw_1ylu3FYWV5xAn2y8E1af85Wn2s1p3p1FmfVTLNEF4zCqri4UPmCnJgqmMqWSigqbmbUw0BfRZwC60aToGeiVLNvBczG_Ur8jsPPoJ7lmTwHZj14IhZuwmN7bgvpelaSOqkgLUjESaIJzT-Pufhn7xIONyly6m66gnq5fpfXePOW4kYr7QtgA4tE |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsJAcIJoxJuiBnzuwfTWWNnalUNjQgupFgoRNNwIW7awl0JojfHvnV2KetHbPpLJZJJ5vwBuBNrIMePUZEKgg0IbzOQJbZiWncS0yRuCxrpANnKCV_t5fD8uwWLbC6PnhH7o4YjIUTHye67l9eoniOXr2srslkt8Wj52Rq5vFN7xHVoMFjP8ltse9P2-Z3ieOwyN6MVVY93RdnJ2YJehQ6gdpbeW6klZ_VYonUPYGyCsND-CkkirUPG2e9eqsN8r0t14LDgvO4ZQcfgmrT8jq8-1nKl6dTJNi5ueEp0RFVbFx7lczpUQkxmR6UJyqYqbiephUKsiToB02iMvMBGryTcBJsOwQL_l0FMop8tU1IBYD00-5SymU3tmc8GaVpw4CVdUEGgn8TrU_wRz9s_fNVSCUa876T5F4TkcbNLlqtPpAsr5-l1cohbO-ZUm4BcIVI4u |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+pyridines+and+pyridazines+with+angiogenesis+inhibiting+activity&rft.inventor=SU+NING&rft.inventor=KLUENDER+HAROLD+C.+E&rft.inventor=LEE+WENDY&rft.inventor=JOE+TEDDY+KITE&rft.inventor=DUMAS+JACQUES+P&rft.inventor=BOYER+STEPHEN+JAMES&rft.inventor=NAGARATHNAM+DHANAPALAN&rft.inventor=SIBLEY+ROBERT+N&rft.inventor=DIXON+JULIE+A&rft.date=2010-09-07&rft.externalDBID=B6&rft.externalDocID=SK287417BB6 |